Tag: Advancement

Investment Strategies

Capricor: A Hold Rating With Regulatory FDA Form Given For Deramiocel Advancement (CAPR)

11/06/2025
mhsj

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…

Asset Allocation

Lexeo: Alignment Gained With FDA Brings Further LX2006 Program Advancement (NASDAQ:LXEO)

05/05/2025
mhsj

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…